Elastomeric core/shell nanofibrous cardiac patch as a biomimetic support for infarcted porcine myocardium

Tissue Engineering - Part A

Volumn 21, Issue 7-8, 2015, Pages 1288-1298

  Ravichandran, Rajeswari ^a,b,c   Venugopal, Jayarama Reddy ^a   Mukherjee, Shayanti ^a   Sundarrajan, Subramanian ^a   Ramakrishna, Seeram ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMIMETICS; CARDIOLOGY; CELL CULTURE; CELLS; CYTOLOGY; DISEASE CONTROL; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; FLOWCHARTING; HEART; NANOFIBERS; PROTEINS; STEM CELLS; TISSUE; TISSUE ENGINEERING;

CARDIAC REGENERATION; CARDIAC TISSUE ENGINEERING; CLINICAL APPLICATION; ENDOTHELIAL CELL MARKERS; FUNCTIONAL IMPROVEMENTS; MESENCHYMAL STEM CELL; MYOCARDIAL INFARCTION; POLIES (GLYCEROLSEBACATE);

SCAFFOLDS (BIOLOGY);

ACTININ; BIOMIMETIC MATERIAL; COLLAGEN; ELASTOMER; FIBRINOGEN; MOLECULAR SCAFFOLD; NANOFIBER; POLITEF; POLY(GLYCEROL SEBACATE); POLYGLYCOLIC ACID; POLYMER; POLYURETHAN; TROPONIN T; UNCLASSIFIED DRUG; VASCULOTROPIN; BIOLOGICAL MARKER; CD31 ANTIGEN; CD68 ANTIGEN, HUMAN; CREATINE KINASE; DIFFERENTIATION ANTIGEN; ELASTOMERIC; LEUKOCYTE ANTIGEN; TROPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMIMETICS; BONE MARROW; CELL DIFFERENTIATION; ENDOTHELIUM CELL; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CELL; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NANOFIBROUS CARDIAC PATCH; NANOTECHNOLOGY; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ECHOGRAPHY; FEMALE; HEART STROKE VOLUME; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PIG;

SUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOMARKERS; BIOMIMETIC MATERIALS; CREATINE KINASE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; NANOFIBERS; POLYMERS; STROKE VOLUME; SUS SCROFA; TISSUE ENGINEERING; TROPONIN;

EID: 84927641259     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0265     Document Type: Article

References (30)

1. Ravichandran, R., Venugopal, J.R., Sundarrajan, S., Mukherjee, S., and Ramakrishna, S. Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease. Int J Nanomed 7, 5969, 2012.
2. Yang, J., Webb, A.R., and Ameer, G.A. Novel citric acidbased bio degradable elastomers for tissue engineering. Adv Mater 16, 511, 2004.
3. Amsden, B., Wang, S., and Wyss, U. Synthesis and characterization of thermoset biodegradable elastomers based on star-poly(caprolactone-co-D, L-lactide). Biomacromolecules 5, 1399, 2004.
4. Yang, J., Zhang, Y., Gautam, S., Liu, L., Dey, J., Chen, W., Mason, R.P., Serrano, C.A., Schug, K.A., and Tang, L. Development of aliphatic biodegradable photoluminescent polymers. Proc Natl Acad Sci USA 106, 10086, 2009.
5. Ravichandran, R., Venugopal, J.R., Sundarrajan, S., Mukherjee, S., and Ramakrishna, S. Poly(Glycerol sebacate)/ gelatin core/shell fibrous structure for regeneration of myocardial infarction. Tissue Eng Part A 17, 1363, 2011.
6. Ravichandran, R., Venugopal, J.R., Sundarrajan, S., Mukherjee, S., Sridhar, R., and Ramakrishna, S. Expression of cardiac proteins in neonatal cardiomyocytes on PGS/ fibrinogen core/shell substrate for Cardiac tissue engineering. Int J Cardiol 167, 1461, 2013.
7. Ravichandran, R., Venugopal, J.R., Sundarrajan, S., Mukherjee, S., Sridhar, R., and Ramakrishna, S. Minimally invasive injectable short nanofibers of poly(glycerol sebacate) for cardiac tissue engineering. Nanotechnology 23, 385102, 2012.
8. Ferrara, N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25, 581, 2004.
9. Olsson, A.K., Dimberg, A., Kreuger, J., and Claesson-Welsh, L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 7, 359, 2006.
10. Lewandrowski, K., Chen, A., and Januzzi, J. Cardiac markers for myocardial infarction. Am J Clin Pathol 118, S93, 2002.
11. Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., Kalantzi, M., Herbots, L., Sinnaeve, P., Dens, J., Maertens, J., Rademakers, F., Dymarkowski, S., Gheysens, O., Van Cleemput, J., Bormans, G., Nuyts, J., Belmans, A., Mortelmans, L., Boogaerts, M., and Van de Werf, F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113, 2006.
12. Strauer, B.E., Brehm, M., Zeus, T., Köstering, M., Hernandez, A., Sorg, R.V., Kögler, G., and Wernet, P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913, 2002.
13. Meyer, G.P., Wollert, K.C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., Hecker, H., Schaefer, A., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113, 1287, 2006.
14. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., Endresen, K., Ilebekk, A., Mangschau, A., Fjeld, J.G., Smith, H.J., Taraldsrud, E., Grøgaard, H.K., Bjørnerheim, R., Brekke, M., Mü ller, C., Hopp, E., Ragnarsson, A., Brinchmann, J.E., and Forfang, K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355, 1199, 2006.
15. Wang, Y.D., Kim, Y.M., and Langer, R. In vivo degradation characteristics of poly(glycerol sebacate). J Biomed Mater Res A 66, 192, 2003.
16. Cohn, J.N., Ferrari, R., and Sharpe, N. Cardiac remodelingconcepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 35, 569, 2000.
17. White, H.D., Norris, R.M., Brown, M.A., Brandt, P.W., Whitlock, R.M., and Wild, C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76, 44, 1987.
18. Hashemi, S.M., Ghods, S., Kolodgie, F.D., Parcham-Azad, K., Keane, M., Hamamdzic, D., Young, R., Rippy, M.K., Virmani, R., Litt, H., and Wilensky, R.L. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 29, 251, 2008.
19. Cleutjens, J.P., Kandala, J.C., Guarda, E., Guntaka, R.V., and Weber, K.T. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27, 1281, 1995.
20. Erlebacher, J.A., Weiss, J.L., Weisfeldt, M.L., and Bulkley, B.H. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol 4, 201, 1984.
21. Sierra, D.H. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomater Appl 7, 309, 1993.
22. Lui, K.O., Zangi, L., and Chien, K.R. Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA. Stem Cell Res 13, 693, 2014.
23. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., Leri, A., and Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701, 2001.
24. Kocher, A.A., Schuster, M.D., Szabolcs, M.J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N.M., and Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7, 430, 2001.
25. Ravichandran, R., Seitz, V., Reddy Venugopal, J., Sridhar, R., Sundarrajan, S., Mukherjee, S., and Ramakrishna, S. Mimicking native extracellular matrix with phytic acidcrosslinked protein nanofibers for cardiac tissue engineering. Macromol Biosci 13, 366, 2013.
26. Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R.W., Lecapitaine, N., Cascapera, S., Beltrami, A.P., D'Alessandro, D.A., Zias, E., Quaini, F., Urbanek, K., Michler, R.E., Bolli, R., Kajstura, J., Leri, A., and Anversa, P. Human cardiac stem cells. Proc Nat Acad Sci USA 104, 14068, 2007.
27. Wollert, K.C., Meyer, G.P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. Intracoronary autologous bonemarrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141, 2004.
28. Bolli, R., Chugh, A.R., D'Amario, D., Loughran, J.H., Stoddard, M.F., Ikram, S., Beache, G.M., Wagner, S.G., Leri, A., Hosoda, T., Sanada, F., Elmore, J.B., Goichberg, P., Cappetta, D., Solankhi, N.K., Fahsah, I., Rokosh, D.G., Slaughter, M.S., Kajstura, J., and Anversa, P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378, 1847, 2011.
29. Hou, D., Youssef, E.A., Brinton, T.J., Zhang, P., Rogers, P., Price, E.T., Yeung, A.C., Johnstone, B.H., Yock, P.G., and March, K.L. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112, I150, 2005.
30. Rashid, S.T., Salacinski, H.J., Hamilton, G., and Seifalian, A.M. The use of animal models in developing the discipline of cardiovascular tissue engineering:a review. Biomaterials 25, 1627, 2004.